Rottner Laura, Metzner Andreas, Ouyang Feifan, Heeger Christian, Hayashi Kentaro, Fink Thomas, Lemes Christine, Mathew Shibu, Maurer Tilman, REIßMANN Bruno, Rexha Enida, Riedl Johannes, Saguner Ardan M, Santoro Francesco, Kuck Karl-Heinz, Sohns Christian
Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
J Cardiovasc Electrophysiol. 2017 Mar;28(3):289-297. doi: 10.1111/jce.13160. Epub 2017 Jan 20.
Three-dimensional electroanatomical mapping (EAM) is an established tool facilitating catheter ablation. In this context, the novel Rhythmia system sets a new bar in fast high-resolution mapping. The aim of this study was to directly compare point-by-point versus rapid ultra-high-resolution EAM in patients scheduled for ablation of atrial fibrillation (AF) with focus on procedural data, acute success, and midterm clinical outcome.
A total number of 74 consecutive patients (48/74 male) with symptomatic AF were scheduled to undergo pulmonary vein isolation (PVI) using either Carto or Rhythmia. The Carto-guided procedures were performed using point-by-point acquisition according to our routine approach, whereas for Rhythmia, fast anatomical mapping was utilized. Comparing Rhythmia- versus Carto-guided ablation approaches, we observed a significantly longer total mapping time (P = 0.001), longer total fluoroscopy time (P = 0.001), more delivered RF-applications (P = 0.019), and longer total RF-duration (P = 0.002). There was no difference regarding total ablation time (P = 0.707), total procedure duration (P = 0.99), and acute procedural success. During follow-up, 84.8% of patients remained free from any AF/AT-recurrence using Carto versus 88.2% when using Rhythmia (P = 0.53). From Kaplan-Meier analysis, the event rate estimations were 15% versus 13.5%, respectively.
The present study reports our first clinical experience using Rhythmia in direct comparison with the established Carto system for AF ablation. Our data clearly demonstrate that Rhythmia was proved to be effective and well applicable but more data will be mandatory before final conclusions can be drawn.
三维电解剖标测(EAM)是一种成熟的辅助导管消融的工具。在此背景下,新型的Rhythmia系统在快速高分辨率标测方面树立了新标杆。本研究的目的是直接比较逐点标测与快速超高分辨率EAM在计划进行房颤(AF)消融的患者中的应用,重点关注手术数据、急性成功率和中期临床结局。
共有74例有症状AF的连续患者(48/74为男性)计划使用Carto或Rhythmia进行肺静脉隔离(PVI)。Carto引导的手术按照我们的常规方法采用逐点采集,而对于Rhythmia,则采用快速解剖标测。比较Rhythmia引导与Carto引导的消融方法,我们观察到总标测时间显著更长(P = 0.001),总透视时间更长(P = 0.001),发放的射频应用更多(P = 0.019),以及总射频持续时间更长(P = 0.002)。在总消融时间(P = 0.707)、总手术持续时间(P = 0.99)和急性手术成功率方面没有差异。在随访期间,使用Carto时84.8%的患者无任何AF/AT复发,而使用Rhythmia时为88.2%(P = 0.53)。根据Kaplan-Meier分析,事件发生率估计分别为15%和13.5%。
本研究报告了我们首次将Rhythmia与成熟的Carto系统直接比较用于AF消融的临床经验。我们的数据清楚地表明,Rhythmia被证明是有效且易于应用的,但在得出最终结论之前还需要更多数据。